Ligand validation:8Q2O

PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8Q2O_PE5_A_504	57%	68%	0.108	0.963	0.57	0.66	-	-	0	0	56%	0.45
8Q2O_PE5_A_505	7%	49%	0.286	0.86	0.69	1.28	-	-	4	0	30%	18.37
4AFK_PE5_A_1516	53%	57%	0.103	0.942	0.41	1.24	-	-	0	0	56%	0.5556
4R36_PE5_B_1001	42%	58%	0.189	0.908	0.67	0.92	-	2	2	0	100%	1
4ETJ_PE5_A_203	38%	46%	0.14	0.913	1.22	0.87	2	-	0	0	59%	0.5926
2YEQ_PE5_A_530	37%	74%	0.11	0.941	0.43	0.57	-	-	0	0	26%	0.2593
4N27_PE5_E_202	36%	57%	0.182	0.901	0.53	1.09	-	1	7	0	85%	0.8519
5CTG_PE5_B_301	35%	74%	0.215	0.925	0.73	0.3	-	-	3	0	89%	0.8889

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.